Wednesday, April 3, 2019

Emcure launches knock-off of Eisai#39;s cancer drug Halaven at 40% lower price in India

Emcure launches knock-off of Eisai#39;s cancer drug Halaven at 40% lower price in India Emcure is confident of overcoming any patent challenge by the innovator, as it claims its version is developed through a non-infringing process.

from Moneycontrol Business News https://ift.tt/2TPjgjD

No comments:

Post a Comment

Paras Defence shares soar 10% as Q2 net profit jumps 50% to Rs 14 crore

Paras Defence and Space Technologies shares surged following strong September quarter results, with net profit jumping 50% and revenue climb...